Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760185 · ClinicalTrials.gov registry record · Phase 2
Pupil Dilation for Treatment of IFIS
A Phase 2 study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT03760185 is a Phase 2 study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 13 participants.
The verdict
NCT03760185, a Phase 2 study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.
Interventions
- DRUG Brimonidine Tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2020-09-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03760185
The ClinicalTrials.gov registry entry for NCT03760185 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brimonidine Tartrate is the first listed.
NCT03760185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03760185 about?
NCT03760185 is a clinical study titled "Pupil Dilation for Treatment of IFIS". A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.
What is the current status of trial NCT03760185?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2019-01-04. Estimated completion is 2020-09-25.
What interventions are being tested in trial NCT03760185?
The interventions under investigation include: Brimonidine Tartrate (DRUG).
Who is sponsoring clinical trial NCT03760185?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.